Compare Expedia Group Inc (EXPE) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expedia Group Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Expedia Group Inc trades at $274.64 (market cap $32.82B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Expedia Group Inc is far larger — about 3.9× Hinge Health Inc. Class A Common Stock's market cap, and Expedia Group Inc pays a 0.7% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expedia Group Inc for 47 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| EXPE | HNGE | |
|---|---|---|
Market Cap | $32.82B | $8.48B |
Volume | 1,337,882 | 879,799 |
Sector | Consumer Cyclical | Health |
52-Week High | $339.13 | $105.14 |
52-Week Low | $188.51 | $31.17 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | $31.38B | $8.10B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Expedia Group (EXPE) trades at $274.69, up 2.32% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a P/E of 17.2, net income margin of 12.97%, and positive cash flow trends. Recent news highlights competitive threats from AI agents but also underscores Expedia's growth in B2B bookings and strategic partnerships.
The outlook for EXPE is positive, supported by earnings momentum and a consensus price target of $335.06, though risks include AI disruption and competitive pressures. Revenue growth and margin expansion present opportunities, but investor caution is warranted given mixed analyst ratings and market volatility.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expedia Group Inc
Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
